Dougan D F, Duffield A M, Duffield P H, Wade D N
Br J Pharmacol. 1986 May;88(1):285-90. doi: 10.1111/j.1476-5381.1986.tb09497.x.
The stereoselective accumulation of alpha-methyl-p-tyramine (AMPT) and alpha-methyl-p-octopamine (AMPO) in rat striatum and hypothalamus after acute and chronic administration of the (+)- and (-)-isomers of amphetamine (Amphet) and the acute administration of (+)- and (-)-AMPT has been investigated by chemical ionization gas chromatography mass spectrometry (c.i.g.c.m.s.). Two h after the administration of (+)- or (-)-AMPT (5 mg kg-1 i.p.), the concentrations of the isomers in striatal tissue were approximately equal; 18 h later, the concentration of the (+)-isomer was 10 times that of the (-)-isomer. The concentrations of AMPO in the striatum and hypothalamus 20 h after administration of (+)-AMPT were 68 ng g-1 and 484 ng g-1 respectively. After the administration of the (-)-isomer of AMPT, small quantities of AMPO were detected in both brain areas. Twenty h after the last of 7 daily injections of (+)-Amphet (5 mg kg-1, i.p.), the concentration of AMPO in the hypothalamus was 5.4 times the concentration at 20 h after one injection. In the striatum, the corresponding ratio for AMPO was 3.5 and for AMPT was 2.5. These data indicate that, although both isomers of AMPT formed from Amphet administered systemically, cross the blood brain barrier, the (+)-isomers AMPT and AMPO are preferentially stored in striatal and hypothalamic aminergic nerve terminals. The accumulations of AMPT and AMPO in rat striatum and hypothalamus after chronic administration of Amphet demonstrates that these metabolites persist in neuronal storage in these brain areas for days after administration. The half-lives of (+)-AMPT and (+)-AMPO in striatal neuronal storage, calculated from this data, were 1.5 days and 2.5 days, respectively. The corresponding half-life for hypothalamic (+)-AMPO was 7 days. 7. These findings suggest the involvement of accumulated AMPT and AMPO in the development of behavioural augmentation to repeated injections of Amphet (Randrup & Munkvad, 1970).
通过化学电离气相色谱质谱法(c.i.g.c.m.s.)研究了急性和慢性给予苯丙胺(Amphet)的(+)-和(-)-异构体后以及急性给予(+)-和(-)-α-甲基-对-酪胺(AMPT)后,α-甲基-对-酪胺(AMPT)和α-甲基-对-章鱼胺(AMPO)在大鼠纹状体和下丘脑的立体选择性蓄积情况。给予(+)-或(-)-AMPT(5mg/kg,腹腔注射)2小时后,纹状体组织中异构体的浓度大致相等;18小时后,(+)-异构体的浓度是(-)-异构体的10倍。给予(+)-AMPT 20小时后,纹状体和下丘脑中AMPO的浓度分别为68ng/g和484ng/g。给予(-)-AMPT异构体后,在两个脑区均检测到少量AMPO。在每日7次注射(+)-苯丙胺(5mg/kg,腹腔注射)的最后一次注射后20小时,下丘脑中AMPO的浓度是单次注射后20小时浓度的5.4倍。在纹状体中,AMPO的相应比值为3.5,AMPT的相应比值为2.5。这些数据表明,尽管全身给予苯丙胺形成的AMPT的两种异构体均能穿过血脑屏障,但(+)-异构体AMPT和AMPO优先储存在纹状体和下丘脑的胺能神经末梢中。慢性给予苯丙胺后大鼠纹状体和下丘脑中AMPT和AMPO的蓄积表明,这些代谢产物在给药后数天内在这些脑区的神经元储存中持续存在。根据这些数据计算,纹状体神经元储存中(+)-AMPT和(+)-AMPO的半衰期分别为1.5天和2.5天。下丘脑(+)-AMPO的相应半衰期为7天。7. 这些发现表明,蓄积的AMPT和AMPO参与了对重复注射苯丙胺行为增强的发展过程(Randrup & Munkvad,1970)。